Graphical Abstract Highlights d BRD2 and to a lesser extent BRD3, but not BRD4, co-localize with CTCF genome-wide d CTCF recruits BRD2 to chromatin, but not vice versa, as shown by genome editing d Disruption of a CTCF/BRD2-occupied element enables inappropriate enhancer activity d BRD2 depletion broadly impairs the integrity of CTCF/BRD2 co-occupied boundaries
In Brief
BET family proteins impact gene expression in multiple ways, and they are pharmacologic targets for various diseases. Hsu et al. show that BRD2 is recruited to CTCF sites where it contributes to CTCF boundary formation and enhancer insulation.
INTRODUCTION
BRD2, BRD3, and BRD4 are members of the bromodomain and extraterminal motif (BET) family of proteins that are critical regulators of transcription. BET inhibitors that competitively target the bromodomain-acetyl lysine interaction have shown great promise in treating cancer and other pathologies and are currently in clinical development. However, much of how BET proteins function remains to be explored. BET proteins are ubiquitously expressed and bind to chromatin via bromodomain association with acetylated histones and/or transcription factors. A leading model is that BET proteins serve as general adaptors that recruit regulatory proteins to chromatin; however, BET inhibition does not result in global, but rather targeted and context-dependent effects on gene expression. Such selective sensitivity to BET inhibition has been attributed to BET protein occupancy at enhancers (Lové n et al., 2013) and recruitment by lineage-specific transcription factors (Asangani et al., 2014; Huang et al., 2009; Lamonica et al., 2011; Roe et al., 2015; Stonestrom et al., 2015) . However, since most BET inhibitors indiscriminately target all family members (Filippakopoulos et al., 2010) , the degree to which BRD2, BRD3, and BRD4 function with distinct regulatory complexes or play unique roles in gene regulation has not been well characterized. Most studies have focused on BRD4 as the primary transcriptional effector, yet several reports have also identified roles for BRD2 in transcriptional activation (Belkina et al., 2013; Stonestrom et al., 2015; Surface et al., 2016; Vardabasso et al., 2015) . How BRD2 functions distinctly from BRD3 and BRD4 remains largely unclear.
Several studies point to a role for BET proteins in both large-scale nuclear structure and chromatin organization. The testes-specific BET, BRDT, is required to maintain centromeric heterochromatin foci during spermatogenesis (Berkovits and Wolgemuth, 2011; Shang et al., 2007) , while BRD4 has been linked to regulating both global (Devaiah et al., 2016; Wang et al., 2012) and gene-specific (Zhao et al., 2011) chromatin compaction. Notably, the yeast BET protein Bdf1 maintains heterochromatin-euchromatin boundaries at telomeres and mating loci, suggesting that BETs can help assemble physical barriers (Ladurner et al., 2003) . In addition, Fs(1)h, a Drosophila BET protein, forms complexes with multiple insulator proteins (Kellner et al., 2013) . Fs (1) h binding increases upon heat shock, a stress that is accompanied by changes in 3D genomic architecture . Yet, whether mammalian BETs also participate directly in insulator or architectural functions remains unclear.
In vertebrates, CCCTC-binding factor (CTCF) contributes to the partitioning of the genome into discrete globular structures termed topologically associating domains (TADs) (Dixon et al., 2012; Nora et al., 2012) . TADs represent megabase-sized A C D B Figure 1 . High Correlation of BRD2 and CTCF Occupancy Genome-wide (A) Genome browser tracks showing ChIP-seq signal for CTCF, BRD2, HA-BRD2, BRD3, BRD4, and GATA1 at the a-globin (Hba) locus. Gray boxes highlight regions of BRD2/CTCF co-localization. All tracks shown are in the estradiol-induced (+GATA1) condition. (B) ChIP-seq signal for the indicated proteins in a 4 kb window centered on CTCF-binding sites in induced G1E-ER4 cells. Each row represents a single peak, ranked from highest to lowest CTCF signal (MACS score).
(legend continued on next page) regions within which loci are more likely to interact with each other than with genomic segments that lie outside. A number of observations suggest that TADs constrain the activity of transcriptional regulatory elements. For example, in some cases, genes within TADs exhibit more correlated expression patterns with each other than with genes in other domains (Flavahan et al., 2016; Nora et al., 2012) , and enhancers typically exert their activity within TAD boundaries (Symmons et al., 2014) . CTCF was initially implicated in the formation of TAD structures due to its strong enrichment at TAD boundaries (Dixon et al., 2012) . Upon deletion of a CTCF site at a TAD boundary, Narendra et al. (2015) observed the spreading of positive regulatory influence across the boundary and upregulation of previously inactive genes. Global depletion of CTCF increases genomic contacts across domain boundaries (Zuin et al., 2014) . Mutations that abrogate CTCF binding at specific boundaries enable ectopic enhancer-promoter contacts between adjacent architectural domains, leading to aberrant gene activation in models of cancer and limb malformation (Flavahan et al., 2016; Lupiá ñ ez et al., 2015) . Taken together, these observations suggest that CTCF both functionally and physically divides the genome into structural domains. However, because the majority of CTCFbound sites are not associated with TAD boundaries (Dixon et al., 2012; Phillips-Cremins et al., 2013) , the context and mechanisms by which CTCF performs its insulating or boundary function at select sites are unknown.
Here we show that the BET protein BRD2 co-localizes with CTCF genome-wide. CTCF is required to recruit BRD2 to cooccupied sites, while CTCF binding is largely BRD2 independent. We present evidence that CTCF forms a functional boundary at the Mitoferrin 1 (Slc25a37) locus by restricting the activity of the Slc25a37 enhancer to prevent aberrant upregulation of a nearby gene. Using single-molecule mRNA fluorescence in situ hybridization (FISH), we find that CTCF, in concert with BRD2, limits the correlation in expression of two genes flanking the boundary. HiC experiments show that BRD2 contributes to chromatin domain boundary function by limiting chromatin contacts across boundaries specifically occupied by BRD2, but not those lacking BRD2. These findings reveal BRD2 as a CTCF cofactor, and they suggest that BET proteins may impact transcription in part through regulating higher-order chromatin architecture.
RESULTS
BRD2 Co-localizes with CTCF Genome-wide BRD2 and BRD4 are each required for gene activation during erythroid maturation driven by the hematopoietic transcription factor GATA1 . However, genomewide analysis of BET localization patterns in the erythroblast cell line G1E-ER4 indicated that they may promote erythroid maturation through distinct mechanisms. Specifically, in contrast to BRD3 and BRD4, BRD2 genome-wide chromatin occupancy does not significantly overlap with that of GATA1, leaving its mechanism of action unresolved . We analyzed BRD2 occupancy patterns in greater depth in relation to chromatin immunoprecipitation sequencing (ChIP-seq) datasets in G1E-ER4 cells from our laboratory and from the Mouse Encyclopedia of DNA Elements (ENCODE) Consortium. G1E-ER4 cells lack endogenous GATA1 and instead express a fusion protein of GATA1 and the ligand-binding domain of the estrogen receptor. The addition of estradiol induces erythroid maturation and activates a red cell-specific gene expression program (Welch et al., 2004 ) (here we refer to the differentiated state as induced G1E-ER4 or +GATA1 and the undifferentiated state as uninduced G1E-ER4 or -GATA1). In induced cells, we observed a striking overlap between BRD2 and the architectural protein CTCF ( Figure 1A ). Overexpression of HA-tagged BRD2 tended to produce broader signals, but displayed a similar pattern of CTCF co-localization. Ranking of CTCF peaks by signal intensity (model-based analysis of ChIP-seq [MACS] score) revealed a strong correlation with BRD2 occupancy ( Figures 1B and 1D ). To a lesser extent BRD3 was also enriched at CTCF sites, possibly reflecting functional overlap between BRD2 and BRD3 ( Figure 1B) . We observed a similar pattern of BRD2 co-localization with CTCF in undifferentiated cells (Figures S1A and S1B). Analysis of DNA sequences under BRD2 peaks using the MEME suite (Machanick and Bailey, 2011) identified a CTCF consensus at 57% of BRD2 sites, supporting extensive BRD2-CTCF co-localization ( Figure 1C ).
Among the known CTCF-binding partners, the cohesin complex in particular occupies a large fraction of CTCF sites in diverse cell types, and it participates in CTCF-mediated insulator function (Parelho et al., 2008; Wendt et al., 2008) and loop formation (Seitan et al., 2013; Sofueva et al., 2013) . Using ChIP-seq datasets from the Mouse ENCODE Consortium in murine erythroleukemia cells (MEL), a related murine erythroid cell line, we found that the occupancy of cohesin subunits RAD21 and SMC3 was highly correlated with CTCF at CTCF-occupied sites in induced G1E-ER4 cells, consistent with their established functional relationship ( Figure 1D ). The correlation between BRD2 and CTCF binding was similar to that observed between cohesin and CTCF, despite possible cell line-specific differences between MEL and G1E-ER4, suggesting that BRD2 may play a similarly important role in mediating CTCF function. At CTCF sites, BRD2 and cohesin also exhibited a strong correlation (Figures 1B and S1C) , suggesting that many CTCF sites are occupied by both BRD2 and cohesin. Even though CTCF and BRD2 can associate with RNA polymerase II (Pol II) (Chernukhin et al., 2007; Denis et al., 2006) , this shared property does not account for their co-localization, as there is little overlap between (C) CTCF motif enrichment analysis using the MEME suite, performed on BRD2-, BRD3-, or BRD4-occupied sites in induced G1E-ER4 cells. The percentage of sites containing a CTCF consensus motif (union of both the MA0139.1 [JASPAR] and CTCF_full [HumanTF1.0] motifs), as well as the distribution of the motif relative to the BET protein peak, are indicated. (D) Pearson correlation coefficients between CTCF (reads per kilobase per million mapped reads [RPKM]) and indicated proteins (RPKM) at CTCF-binding sites. RAD21 and SMC3 ChIP-seq data are from ENCODE datasets in MEL cells. See also Figure S1 . Pol II (datasets from Hsiung et al., 2016) and BRD2 occupancy patterns at CTCF-occupied sites (Figures 1B and S1B) .
Consistent with previous reports (Anders et al., 2014) , we also noted some places, such as the a-globin genes (Hba), at which BRD2, BRD3, and BRD4 were all bound ( Figure 1A ). However, BRD4 was not highly enriched at CTCF sites genome-wide (Figure 1B) , and it did not correlate well with CTCF occupancy (Figure 1D ), pointing to possible unique functional roles for BRD2 and BRD4.
CTCF Is Required for BRD2 Occupancy at Cobound Sites
The significant co-occupancy of BRD2 and CTCF suggests they may facilitate each other's association with chromatin, similar to what has been described for BET proteins in the context of GATA1 or the androgen receptor (Asangani et al., 2014; Lamonica et al., 2011; Stonestrom et al., 2015) . To test if BRD2 promotes CTCF binding, we performed ChIP-seq of CTCF in two independent G1E-ER4 clonal sub-lines, in which BRD2 was depleted by CRISPR/Cas9 (BRD2 knockout [KO] cell lines 1 and 2; Figure S2A ), and unedited control G1E-ER4 cells. CTCF occupancy was unchanged at the majority of sites examined, including the a-globin locus (Figure 2A ). When we compared CTCF signal intensities in control and BRD2-depleted cells genome-wide ( Figure 2B ), we found they were very similar among the two BRD2 KO cell lines and control cells (Pearson correlation coefficients: BRD2 KO 1 versus BRD2 KO 2 = 0.84; control versus BRD2 KO 1 = 0.73; control versus BRD2 KO 2 = 0.73) ( Figure 2B ), indicating that CTCF chromatin occupancy is largely BRD2 independent. These results were confirmed using ChIP-qPCR at select CTCF sites ( Figure S2B ). Given that cohesin is present at many CTCF/BRD2 co-occupied sites, we tested whether BRD2 is required for cohesin recruitment at CTCF sites. ChIP-qPCR using antibodies against the cohesin subunit SMC1 showed that its occupancy was unaffected by BRD2 depletion at the majority of CTCF/BRD2 sites examined ( Figure S2C ), suggesting that BRD2 is dispensable for cohesin binding at CTCF sites.
BET proteins are recruited by transcription factors in diverse contexts (Asangani et al., 2014; Huang et al., 2009; Lamonica et al., 2011; Roe et al., 2015; Shi et al., 2014; Stonestrom et al., 2015; Wu et al., 2013) . To determine if BRD2 requires CTCF to occupy chromatin, we used CRISPR/Cas9-mediated homology-directed repair to mutate a specific CTCF site upstream of the Bcl11a locus ( Figure 2C ). We introduced nine point mutations in the CTCF consensus sequence (Bcl11a-CTCF_Mut) that created an NdeI restriction site previously shown to eliminate CTCF binding in vitro (Szabó et al., 2004) . This approach avoids the confounding effects of larger deletions or insertions that may further alter the structure of the locus. As predicted, these mutations abrogated CTCF binding in vivo (Figure 2D) . ChIP-qPCR revealed that BRD2 occupancy was lost in the absence of CTCF at this site, but not at control regions where CTCF binding remained intact ( Figure 2D ). The expression of the surrounding genes was unaffected ( Figure S2D ), indicating that loss of BRD2 at this site was not a result of transcriptional changes at the locus. In sum, these data indicate that CTCF mediates BRD2 chromatin association, but not vice versa.
CTCF Defines a Functional Boundary at the Slc25a37 Locus CTCF has diverse roles in transcriptional regulation, including gene activation and repression, enhancer blocking, splicing, and forging long-range chromatin interactions (Phillips and Corces, 2009 ). To determine if BRD2 participates in any of these CTCF functions, we first perturbed CTCF in a locus-and sitespecific manner. We focused on the Slc25a37 locus, or Mitoferrin 1, which contains a gene encoding a mitochondrial iron transporter required for erythroid maturation (Shaw et al., 2006) . Three GATA1-occupied regulatory regions downstream of the Slc25a37 gene function as enhancer elements and are in physical proximity with the Slc25a37 promoter Hughes et al., 2014) . Two CTCF sites (CTCFa and CTCFb; Figure 3A ) separate the enhancer from a neighboring gene, Entpd4, suggesting that they may function as boundary or insulator elements to prevent the enhancer from inappropriately regulating Entpd4. Consistent with this possibility, chromatin interactions with the Slc25a37 promoter drop off significantly at these CTCF sites in Capture-C experiments (Hughes et al., 2014) ( Figure S3A ), and disruption of the GATA1-dependent enhancer elements reduces Slc25a37 expression, but has no effect on the expression of Entpd4 . BRD2 co-localizes with CTCF at both CTCFa and CTCFb ( Figure 3A ).
Using CRISPR/Cas9, we generated two independent clones with either biallelic deletions or combined deletions/insertions disrupting all or part of the CTCFa consensus sequence, Slc25a37-CTCFa_Mut1 and Mut2 ( Figure S3B ). ChIP-qPCR confirmed loss of occupancy by both CTCF and an HA-tagged form of BRD2 ( Figure 3B ). CTCF and HA-BRD2 binding at the second site, CTCFb, were unaffected by these mutations (Figure S3C ). Attempts to mutate both CTCFa and CTCFb failed for unknown reasons. To examine the transcriptional consequences of disrupting CTCFa, we measured the expression of the surrounding genes. Slc25a37 levels changed little, if at all, Pos. Neg. Pos.
Control Control
Control Control (legend continued on next page) in both clones. However, the expression of Entpd4 was upregulated $3-fold ( Figure 3C ). Notably the increase in Entpd4 expression was GATA1 dependent, suggesting it results from inappropriate activation by the GATA1-regulated Slc25a37 enhancer. Other genes normally activated during erythroid maturation were unaffected ( Figure S3D ). These results are consistent with a role for CTCF in enhancer blocking or boundary formation.
To directly test whether CTCF restricts the Slc25a37 enhancer from contacting the Entpd4 gene, we performed chromosome conformation capture (3C). Both Slc25a37-CTCFa mutant cell lines exhibited increased interaction frequency between the Slc25a37 enhancer and the Entpd4 promoter ( Figure S4B ), indicating that CTCF serves to block enhancer contacts at this locus. One mechanism by which CTCF may perform its insulating function is through the pairing with other convergently oriented CTCF sites that demarcate a given contact domain (de Wit et al., 2015; Guo et al., 2015; Rao et al., 2014) . The CTCFa and CTCFb motifs are both oriented in the reverse (left) direction ( Figure 3A ), suggesting their loop orientation is similar. We speculate that the effect sizes of inappropriate upregulation of Entpd4 expression and contacts with the Slc25a37 enhancer would have been greater had we been able to disrupt both CTCF sites simultaneously, similar to what has been observed at the Hox gene clusters (Narendra et al., 2015) .
A direct test of BRD2's role in the function of this boundary is hampered by the lack of a means to perturb BRD2 binding in a site-specific fashion. Global BRD2 depletion reduced expression of Slc25a37 ( Figure S4A ), likely due to BRD2 enrichment at the Slc25a37 promoter and enhancer ( Figure 3A ), while Entpd4 levels were relatively unaffected. Moreover, the Slc25a37 enhancerpromoter contacts were diminished in the absence of BRD2 as measured by 3C ( Figure S4C ), indicating that the Slc25a37 enhancer requires BRD2 for its full activity. The weakening of the Slc25a37 enhancer in the absence of BRD2 complicates the assessment of whether BRD2, similar to CTCF, limits the range of Slc25a37 enhancer activity. Using 3C we observed a subtle trend toward increased contacts between the Slc25a37 enhancer and the Entpd4 promoter upon BRD2 loss, but it did not reach statistical significance ( Figure S4C ). It is possible that direct or indirect effects from BRD2 depletion obscure potential increases in both Entpd4 levels and contacts between the Slc25a37 enhancer and Entpd4 promoter. Hence, we pursued an independent strategy to detect perturbed boundary strength by examining the degree of correlation in expression of genes flanking the boundary, as described in the following section.
BRD2 Potentiates CTCF Boundary Function in Single Cells
Loss of the Slc25a37-CTCFa site renders Entpd4 GATA1 responsive and increases contacts between the Slc25a37 enhancer and Entpd4, suggesting that the two genes now share the regulatory influence of this enhancer. To test whether Slc25a37 and Entpd4 are co-regulated in the absence of CTCFa, we examined their expression in individual cells by quantitative single-molecule mRNA FISH Raj et al., 2008) . This method is based on the use of fluorescent probes targeting exons and allows the counting of individual Slc25a37 and Entpd4 mRNAs. The absolute mRNA counts of Slc25a37 and Entpd4 reflected gene expression changes observed in bulk populations ( Figure S5A ), with cells from both Slc25a37-CTCFa mutated lines exhibiting elevated Entpd4 levels compared to control cells, and the levels of Slc25a37 remaining unchanged. We next assessed the correlation in mRNA levels in single cells, as depicted in the model shown in Figure 4A . A low correlation suggests that Slc25a37 and Entpd4 have little regulatory relationship, while a high correlation implies that the two genes share regulatory control. We note that such a relationship cannot be observed in bulk mRNA measurements in which, for example, two cell populations could have equal total mRNA levels of two genes but exhibit distinct levels of each transcript in individual cells (as illustrated in Figure 4A ). To test this we plotted the number of mRNA molecules per cell of each gene from either control or Slc25a37-CTCFa mutant populations, and we measured the correlation coefficient across three biological replicates ( Figures  4B-4D ). In control cells, expression of Slc25a37 and Entpd4 exhibited a low level of correlation. Deletion of the intervening CTCFa site significantly increased their correlation ( Figures  4B-4D ) in both Slc25a37-CTCFa mutant lines.
We considered that the observed changes in correlated gene expression could result from other confounding factors. For example, assume that two genes have equal transcription rates in every cell, but that this rate varies from cell to cell. At high transcript levels, a strong correlation between transcript counts would be observed. However, at low transcript abundances, the effects of random counting noise would play a disproportionate role, resulting in a decreased observed correlation despite the exact equivalence in transcription rate in every cell. In the present case, Entpd4 expression was lower in control cells, raising the possibility that a potential correlation with Slc25a37 expression was masked due to low molecule number noise. To test this possibility, we scaled down the levels of Entpd4 in the Slc25a37-CTCFa-mutated lines such that the means of control and mutant populations were equivalent. We then added random sampling error to the number of Entpd4 mRNA molecules, thus mimicking counting errors at low expression levels. We found that, while some of the increased correlation in the mutant could be explained this way, the difference in correlation between the Slc25a37-CTCFa mutant and control populations remained intact ( Figure S5B ). To increase the analytical stringency, we scaled the levels of Entpd4 in the Slc25a37-CTCFa mutated lines down to half that of control levels. While the correlation in the Slc25a37-CTCFa mutated cells decreased further, it still remained higher than in the control setting (unpublished data). Transcript abundance can correlate with cell size (Padovan-Merhar et al., 2015) . To control for possible effects of cell size differences between populations, we normalized Entpd4 mRNA levels to cell area, and we measured the correlation between Slc25a37 and Entpd4. The correlation between these two genes in the boundary-mutated cells remained higher, demonstrating that possible cell size differences were not a main contributing factor ( Figure S5C ). In concert, these results further support that CTCF prevents the Slc25a37 enhancer from acting on the Entpd4 gene.
To test whether BRD2 participates in CTCF's boundary function at this locus, we performed mRNA FISH on BRD2-depleted cells ( Figure 4E ). Absolute mRNA measurements of Slc25a37 and Entpd4 were consistent with qRT-PCR analysis ( Figures  S4A and S5D) . Notably, in both BRD2-deficient clones the two genes displayed an increased correlation in their expression ( Figures 4E and 4F) relative to control cells. In comparing the difference between correlation coefficients, we found that one BRD2-depleted clone reached statistical significance relative to control cells (BRD2 KO 2, p = 0.018, t test), while the other showed the same trend but fell short of statistical significance (BRD2 KO 1, p = 0.069, t test). Within each of the four biological replicates of this experiment, we noted that, with one exception, the correlation between the two genes was increased in the BRD2-depleted clones relative to control cells ( Figure S5E ). While we included all replicates in our pooled comparisons, thus explaining why there is some degree of variability in the data, the consistency of the trend within the majority of experiments supports that the two genes are indeed more correlated in the absence of BRD2. The increased correlation in BRD2depleted cells remained intact after normalizing for cell area (Figure S5C ). We noted that performing a similar simulation as described above, in this case scaling down the levels of Slc25a37 in control cells such that the means of control and BRD2 KO populations were equivalent, did not significantly alter the results (unpublished data), suggesting that changes in overall transcript abundances were not driving the differences in correlation that we observed.
While we cannot rule out potentially confounding secondary effects from sustained BRD2 depletion, these results suggest that BRD2 supports CTCF's ability to partition transcriptional regulatory elements at this locus.
Loss of BRD2 Weakens BRD2-Occupied Boundaries CTCF's function as an insulating or boundary element may be linked to its role in organizing genome architecture. To assess whether BRD2 regulates chromatin structure and whether this function overlaps with that of CTCF, we generated 40 kb resolution in situ HiC maps in control G1E-ER4 cells and two BRD2depleted cell lines. Two biological replicates for each cellular condition generated a total of $934 million unique interaction pairs (control, $323 million; BRD2 KO 1, $301 million; BRD2 KO 2, $310 million) ( Figure S6A ; Table S1 ). Since BRD2 is required for erythroid differentiation, experiments were performed in uninduced cells (ÀGATA1) to avoid potentially confounding effects of differences in maturation. The raw reads from biological replicates were highly correlated with one another, demonstrating the reproducibility of the experiment and allowing us to merge the two replicates for all subsequent analysis. We corrected for inherent biases in HiC maps via matrix balancing, and we visualized contact frequency heatmaps binned at 40 kb resolution. We used the Kit locus as a benchmark to determine whether our HiC data captured known structural features ( Figure S6B ). In the 2 Mb region surrounding Kit, we observed domain structure highly similar to published HiC data in mouse embryonic stem cells (mESCs) (Dixon et al., 2012) and CH12-LX cells (Rao et al., 2014) . While the larger domain structure was similar between cell lines, cell type-specific differences surrounding Kit emerged at the sub-domain level ( Figure S6B ).
CTCF has been implicated in the formation and maintenance of architectural domain boundaries. To define such boundaries, we computed the directionality index for each 40-kb bin in the genome by comparing the bin's interactions with the 50 bins (2 Mb) immediately upstream and downstream. We then applied the Hidden Markov Model approach proposed by Ren and colleagues (Dixon et al., 2012) to call 1,814 domains (median size 920 kb) in our control cells. Supporting the validity of this method, domain calls showed strong correlation with the visual representation of large-scale domain structure in the heatmaps (Figures 5A, 5B , and S6B). We note that these regions are likely comparable to megabase-scale TADs identified in published work (Dixon et al., 2012; Nora et al., 2012) ; however, we refer to them as domains and domain boundaries for simplicity.
We next determined whether domain boundary structure was affected by BRD2 depletion. Contact maps uncovered a spectrum of structural perturbations at individual boundaries, with the most common being an increase in ectopic, shortrange interactions across boundaries (Figures 5A and 5B ) and a blurring of the transitions between domains, including rare but dramatic boundary disruptions ( Figure S6C ). To determine whether domain boundary disruption was associated with (D) Average insulation scores centered on boundaries called at 40 kb resolution in control G1E-ER4 cells or either of the two BRD2 KO cell lines (1 and 2) at the indicated boundary category (error bars represent 2.5th and 97.5th percentiles of the distribution of the sampling means generated via a bootstrapping procedure in which the insulation score values of boundaries in a particular class were sampled with replacement 1,000 times). See also Figure S6 and Tables S1-S3, S4, and S5. altered transcriptional regulation, we measured expression of the genes surrounding the boundaries in Figures 5A and S6C  (Figure S6G ). Some genes (Sec16b from the locus in Figure 5A and Xrcc4 from the locus in Figure S6C ) were downregulated, while others were either unaffected (Rasal2 and Tmem167) or increased (Ralgps2 from the Figure 5A locus) upon BRD2 depletion ( Figure S6G ). We note that we cannot distinguish whether the changes in chromatin structure causally underlie the changes in gene expression at these regions, nor can we rule out a role for BRD2 in regulating transcription independent of any architectural function. However, the observation that transcription can be upregulated suggests that domain perturbations might lead to enhancer miswiring across domains.
To measure the contributions of CTCF and BRD2 to boundary formation genome-wide, we classified boundaries by their BRD2 and CTCF occupancy within ±20 kb of the boundary position (Table S4) . We called a set of high-confidence BRD2 and CTCF peaks in control G1E-ER4 cells, and we intersected these to find regions of the genome with high BRD2/CTCF occupancy. To distinguish sites uniquely occupied by either BRD2 or CTCF, we additionally called a set of low-confidence peaks, and we used these to rule out occupancy by the other factor. Boundaries were parsed into the following categories: (1) those with BRD2 without CTCF, (2) those in which CTCF and BRD2 were directly co-localized with no additional CTCF-only or BRD2-only sites (CTCF/BRD2 co-occupied only), (3) those in which CTCF and BRD2 were directly co-localized with additional BRD2-only sites (CTCF/BRD2 co-occupied with BRD2-only), (4) those in which CTCF and BRD2 were directly co-localized with additional CTCF-only sites (CTCF/BRD2 co-occupied with CTCF-only), (5) those with CTCF without BRD2, and (6) those that lacked either protein (neither) (see Figure 5C ; Tables S2 and S4 ). All boundaries containing multiple classes of co-localized sites and/or peaks that did not meet our stringent thresholds were classified as ''other'' and were not included in the analysis. We validated this strategy by examining ChIP-seq peak enrichment in each category ( Figure S6H ). Our classification scheme suggests domain boundaries exhibit diverse signatures of BRD2 and CTCF occupancy.
To quantify changes in boundary strength upon BRD2 depletion, we computed the insulation score for every boundary within a given classification in control and BRD2 KO cells. The insulation score aggregates the number of interactions in a sliding window along the linear chromosome (Crane et al., 2015) . A less well-insulated region, characterized by a high frequency of interactions passing over, would have a concomitantly high insulation score. A 5-by-5 bin (200-by-200 kb) sliding window was used to quantify insulation scores across boundaries. The relative change (log2 scale) in insulation score for each boundary between control and BRD2 KO cells was plotted as a histogram for each boundary category ( Figure 5C, top panels) . We compared these to empiric null distributions created by computing the log2 fold changes in boundary insulation score between BRD2 KO 1 and BRD2 KO 2 cells ( Figure 5C, bottom panels) . When each category was examined individually, we observed an increase in insulation score (corresponding to a gain of interactions across the boundary) at boundary classes containing BRD2 ( Figure 5C ; Table S2 ). The boundaries most affected by BRD2 loss had CTCF/BRD2 co-occupied sites with additional BRD2-only sites. Effects were also present at boundaries containing BRD2 without CTCF, boundaries with CTCF/BRD2 co-occupied only sites, or CTCF/BRD2 co-occupied with CTCF-only sites ( Figure 5C ; Table S2 ). Importantly, CTCF-only boundaries and boundaries devoid of CTCF and BRD2 were essentially unperturbed in the BRD2 KO cells, suggesting the effect is specific to BRD2-occupied regions. The shift in insulation score was mostly driven by relatively modest changes at a substantial proportion of BRD2/CTCF boundaries rather than large alterations at a small fraction ( Figure 5C ). These data indicate that BRD2 contributes to the demarcation of domain boundaries.
To better understand the link between BRD2 and higher-order chromatin architecture, we visualized the average insulation scores in each boundary category as line graphs in which boundaries appear as local minima. Again, the most perturbed boundaries in BRD2-depleted cells were those containing BRD2, as evidenced by an increase in insulation score (or interaction frequency) across boundaries. Boundaries lacking BRD2 remained intact ( Figure 5D ), suggesting that BRD2 potentiates domain boundary integrity. To ensure that our results were robust to the resolution of our HiC data, we also conducted our insulation score analyses at 10-kb resolution (Tables S3 and S5 ), and we observed very similar effects of BRD2 depletion on the shifts in insulation score (Figures S6D-S6F ). Even at higher resolution, we could still observe a substantial number of significantly weakened BRD2-occupied boundaries, whereas the impact on boundaries without BRD2 was negligible ( Figures S6D-S6F ; Table S3 ). We also observed that, at both resolutions, the strongest effects on insulation score tended to occur at domain boundaries.
We note that the datasets generated in this study will allow for much broader analyses of domain architecture, as well as intradomain looping interactions at various length scales. Space constraints precluded us from presenting more permutations of the analyses, but the datasets are publicly available for further study. Taken together, our results indicate that BRD2 is required to maintain chromatin domain integrity and may operate through both CTCF-dependent and CTCF-independent mechanisms.
DISCUSSION
Our work uncovers a functional link between the architectural protein CTCF and the BET protein BRD2 in large-scale chromatin organization. BRD2 and to a lesser extent BRD3 are co-localized with CTCF genome-wide. Loss of BRD2 is accompanied by widespread alterations in domain boundaries, characterized by an increase in ectopic cross-boundary chromatin contacts, particularly involving regions at which both BRD2 and CTCF are present. While BET proteins are well known for their ability to recruit transcriptional co-regulators to acetylated chromatin, a role in maintaining domain-level chromatin architecture has not previously been appreciated.
BET proteins can facilitate chromatin occupancy of DNA-binding proteins (Lamonica et al., 2011; Stonestrom et al., 2015) , but CTCF binding occurs normally in the absence of BRD2, suggesting that BRD2 functions downstream of CTCF. However, given that BRD3 can also occupy CTCF sites, a compensatory role for BRD3 in aiding CTCF DNA binding remains possible. Indeed, the yeast BET homolog Bdf2 responds to Bdf1 loss by shifting its occupancy to Bdf1 sites (Durant and Pugh, 2007) .
BET proteins associate with chromatin not only via acetylated histones but also acetylated transcription factors (Asangani et al., 2014; Huang et al., 2009; Lamonica et al., 2011; Roe et al., 2015; Shi et al., 2014) . Whether the CTCF-BRD2 interaction is direct and whether it requires acetylation of CTCF or another CTCF cofactor remain open questions. Conventional co-immunoprecipitation experiments failed to detect an association between BRD2 and CTCF (unpublished data), but it is possible that the interaction occurs in the context of chromatin or is sensitive to extraction conditions. Disruption of one of two CTCF sites that normally separate the erythroid-specific gene Slc25a37 from its independently regulated neighbor Entpd4 enabled the activity of the GATA1controlled Slc25a37 enhancer to inappropriately contact the Entpd4 promoter and activate Entpd4 expression in a GATA1dependent fashion. Thus, at this site, CTCF functions as part of a boundary mechanism that constrains enhancer action. Since BRD2 occupancy cannot be easily disrupted locally, we examined the activity of this boundary in BRD2-depleted cells. BRD2 deficiency does not augment Entpd4 expression and, thus, does not phenocopy the bulk transcriptional effects of the specific CTCF site mutation. However, the interpretation of this experiment is confounded by the reduced expression of Slc25a37 in BRD2-depleted cells and the decreased contacts between the Slc25a37 enhancer and Slc25a37 promoter, indicating that the enhancer is less active in this context. Population-based gene expression studies are limited in that they might obscure transcriptional relationships that occur at the single-cell level. We therefore used single-molecule mRNA FISH to quantify the number of Slc25a37 and Entpd4 mRNA molecules per cell, and we measured their correlation. CTCF site mutation at the boundary as well as global BRD2 loss elevated the correlation in expression of both genes. Although global BRD2 loss could have indirect effects, such as the depletion of other factors involved in maintaining this boundary element, these observations suggest that, in the absence of CTCF or BRD2, the genes share transcriptional regulatory mechanisms. This supports the model that BRD2 contributes to CTCF's ability to limit enhancer activity, and it highlights the power of RNA FISH to probe correlative relationships of gene expression. The effect of BRD2 deple-tion on the Slc25a37/Entpd4 boundary was not as strong as that following the disruption of CTCF. This might be due to partial compensation by BRD3 or to CTCF exerting some of its activity independently of BET proteins. Conversely, a fraction of BRD2occupied sites lacks CTCF, indicating that BRD2 can also function in a CTCF-independent manner.
CTCF's role as a boundary or insulator element may be related to its ability to organize higher-order chromatin architecture (Phillips and Corces, 2009 ). CTCF anchors long-range chromatin interactions (Phillips-Cremins et al., 2013) , and its disruption increases inter-domain chromatin contacts (Narendra et al., 2015; Zuin et al., 2014) . Our HiC analysis revealed that loss of BRD2 similarly increases contact frequencies across BRD2occupied domain boundaries genome-wide, demonstrating that BRD2 globally contributes to domain insulation. The mechanism by which BRD2 functions in this context remains an open question. CTCF is thought to form chromatin loops, which might structurally partition the genome. BRD2 has a putative dimerization domain (Garcia-Gutierrez et al., 2012) that could aid in forging chromatin contacts. Alterations in chromatin interactions in BRD2-deficient cells were accompanied by changes in gene expression, suggesting at a correlative level that the relaxing of boundaries enables enhancer rewiring or enhancer promiscuity. However, given that these experiments involved sustained BRD2 depletion, it is also possible that the architectural changes are a corollary of disrupted transcription or indirectly result from loss of factors involved in looping or insulation.
Previous reports suggested that BRD2, BRD3, and BRD4 bind to overlapping sets of transcriptional regulatory complexes (Dawson et al., 2011; Rahman et al., 2011) and exhibit significantly overlapping occupancy at active genes (Anders et al., 2014) . Our study underscores key differences between the functions of individual BET family members by showing that, in contrast to BRD2 and BRD3, BRD4 is not enriched at CTCF sites. Also, a prior study in erythroid cells found that BRD2, BRD3, and BRD4 exhibit distinct localization patterns in relation to the erythroid transcription factor GATA1 and, thus, are likely to exert disparate functions in promoting erythroid maturation . That study, similar to the present one, also suggested functional overlap between BRD2 and BRD3. Several important questions remain for future studies. What is the molecular basis underlying the selective recruitment of BET proteins by distinct sets of transcription factors? Do CTCF sites co-bound by BRD2 have functions disparate from CTCF sites that do not recruit BRD2? To what degree can BRD2 form boundaries or architectural domains at places where CTCF is not also present? And, more broadly, what distinguishes CTCF and BRD2 sites at boundaries from those that lie in non-boundary chromatin? Finally, to what extent does this function of BRD2 relate to the organization of smaller scale structures, such as enhancer-promoter loops?
In concert, our findings indicate that BRD2 acts to augment the boundary function of CTCF both by limiting the spread or range of enhancer activity and by physically preventing the formation of cross-boundary contacts genome-wide ( Figure 6 ). This implies that pharmacologic BET inhibitors may alter transcriptional regulation on a broader scale as a result of domain boundary perturbations.
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Experimental Model and Subject Details G1E-ER4 cells are a sub-line of G1E cells, (derived from GATA1 À/À murine embryonic stem cells; Weiss et al., 1997) , which express GATA1 fused to the ligand binding domain of the estrogen receptor (GATA1-ER) introduced by a retrovirus (Weiss et al., 1997) . GATA1 activation and erythroid maturation are induced by the addition of 100nM estradiol to the media for 24 hr (''+GATA1''). Where indicated, cells were used in the undifferentiated (''-GATA1'') state, and are referred to as ''uninduced.'' G1E-ER4 cells were grown in IMDM+15% FBS, penicillin/streptomycin, Kit ligand, monothioglycerol and epoetin alpha in a standard tissue culture incubator at 37C with 5% CO2. For G1E-ER4 lines expressing HA-BRD2, cells were infected with MigR1-HA-BRD2 retrovirus, which contains IRES-GFP. HA-BRD2 was cloned into the MigR1 vector from mouse cDNA . Following infection, cells were expanded and GFP+ cells were sorted on a FACS Aria II (BD Biosciences) to obtain pure populations.
BRD2-depleted (''BRD2 KO'') cell lines were derived by cotransfection of G1E-ER4 cells with MigR1-Cas9 (mCherry) and MigR1guide RNA (GFP) targeting the Brd2 locus (BRD2_gRNA) using the Amaxa electroporator (Lonza). Single mCherry+/GFP+ cells were sorted 24 hr later into 96-well plates. Cells were expanded and clones were screened with a combination of PCR, Sanger sequencing and immunoblot.
Bcl11a-CTCF_Mut cell line was generated by co-transfection of G1E-ER4 cells with pX330-U6-Chimeric_BB-CBh-hSpCas9 Cas9/ guide RNA plasmid (with GFP) (Paralkar et al., 2016) IDT). Single cells were sorted, expanded as above, and screened using a combination of PCR, restriction digest and Sanger sequencing. Slc25a37_CTCFa_Mut cell lines were derived by transfection with the pX330 Cas9/guide RNA plasmid as above with Slc25a37_CTCFa_Mut#1 or Mut#2 guide RNAs cloned in, and sorted and expanded as above. Clones were screened using PCR and Sanger sequencing, followed by ChIP-qPCR to confirm CTCF binding disruption. Allele sequences were determined by TOPO-TA cloning a PCR product encompassing the edited region, followed by sequencing.
See Key Resources Table for guide RNA and repair template sequences.
METHOD DETAILS

Retroviral infection of murine cells
To generate G1E-ER4 cells stably expressing HA-BRD2, cells were infected with a MigR1-HA-BRD2 retrovirus. Retrovirus was produced as previously described in HEK293T (Tripic et al., 2009 Table. All guide RNA sequences were designed using the CRISPR design tool (crispr.mit.edu) (Cong and Zhang, 2014) .
Identifying BRD2, CTCF sites to classify boundaries ChIP-seq peak calling was performed with MACS2 using parameters for punctate (CTCF; -p 1E-8) and diffuse (BRD2; -p 1E-8-broad-broad-cutoff 1e-4) chromatin marks. To address the challenge of peak calling BRD2 signal, we performed intersections to keep the enriched signal called with-broad-cutoff 1e-2 that also intersected peaks called with-broad-cutoff 1e-4. The result of this intersection is the detection of both punctate and diffuse BRD2 sites via the capture of the breadth of moderateconfidence BRD2 signal surrounding narrower high-confidence BRD2 peaks. To find genomic loci co-occupied by high-confidence CTCF and BRD2, we intersected CTCF and BRD2 peaks and vice-versa, and then the results of the intersections were concatenated and merged. To identify exclusively occupied sites, we subtracted low-confidence occupancy regions for CTCF from the highconfidence peak calls for BRD2 and vice-versa. We parsed low-confidence occupancy regions in the genome as zones of possible but low-signal binding using -p 1e-2 (CTCF) or-broad-cutoff 1e-2 (BRD2). The subtraction operations ensured that regions of moderate-confidence binding of either protein are excluded from the stringent exclusive site list.
Contact domain calling and categorization
Contact domains were identified in control uninduced G1E-ER4 cells by applying the directionality index (DI) and a Hidden Markov Model (Dixon et al., 2012) . We called two sets of domains: one set on the 40kb interaction matrices, using a 50 bin (2Mb) window in both the upstream and downstream direction to compute the directionality index; and a second set on the 10kb interaction matrices, using a 100 bin (1Mb) directionality index window (boundary locations are provided in Tables S4 and S5 ). We defined domain boundaries as the endpoints of each domain called, except in cases where the next domain was over 400kb away, suggesting a stretch of generally disorganized chromatin rather than a specific boundary. Disorganized chromatin regions were not considered in downstream analyses. We detected 1,814 domains (median size 920kb) in our 40 kb contact matrices from control uninduced G1E-ER4 cells. Moreover, by using a smaller directionality index computation window (100 bins) on our higher resolution 10 kb contact matrices, we identified a larger set of 3,214 domains of smaller size (median size 470kb) in control cells, These results are consistent with the notion that large domains such as TADs are further arranged into a nested set of overlapping sub-domains. Control cell contact domain boundaries were then classified based on the presence or absence of nearby high-confidence CTCF and BRD2 ChIP-seq peaks. Boundaries were parsed into categories based on which combinations of these factors were found near the boundary, including: (1) those with BRD2 without CTCF, (2) those in which CTCF and BRD2 are directly colocalized, with no additional CTCF-only or BRD2-only sites (''CTCF/BRD2 co-occupied only''), (3) those in which CTCF and BRD2 are directly colocalized with additional BRD2-only sites (''CTCF/BRD2 co-occupied with BRD2-only''), (4) those in which CTCF and BRD2 are directly colocalized with additional CTCF-only sites (''CTCF/BRD2 co-occupied with CTCF-only''), (5) those with CTCF without BRD2, (6) those that lack either protein (''Neither''), and (7) all ''Other'' boundaries containing multiple classes of colocalized sites and/or peaks that did not meet our stringent thresholds. This ''Other'' category ensures the stringency of categories (1)-(6) by including cases where high-confidence BRD2 was present together with moderate-confidence CTCF (or vice-versa), as well as cases where exclusive CTCF and exclusive BRD2 sites were both found near the boundary call. When categorizing the boundaries of domains called on 40kb contact matrices, we considered ChIP-seq peaks within 20kb of the boundary coordinate, in accordance with the ± 20kb uncertainty inherent in identifying a coordinate on a 40kb binned matrix. Similarly, when categorizing the boundaries of domains called on the 10kb contacted matrices, we considered ChIP-seq peaks within ± 20kb of the boundary coordinate. The number of boundaries classified into each category is shown in Tables S2 and S3 .
Insulation score analysis
To enable comparison between samples, ICED corrected HiC libraries were parsed into contact matrices for each chromosome and then quantile normalized (Bolstad et al., 2003; Bullard et al., 2010) . Bin-bin pairs with ICED values lower than 0.01 were excluded from quantile normalization and downstream analyses. Our normalization approach resulted in the equalization of global counts distributions across different samples while preserving underlying biological differences unique to each condition.
To assess the relative strength of contact domain boundaries using our 40kb contact matrices, we computed an insulation score as the sum of a 5 bin by 5 bin (200kb by 200kb) window positioned adjacent to the diagonal at the bin of interest as in (Crane et al., 2015) . We positioned two windows over the bins immediately upstream and downstream of the boundary (''-1'' and ''+1,'' respectively), and then slid the windows away from the boundary until they no longer overlapped a previous window. This allowed the boundary position to emerge as a relative minimum in insulation score relative to the surrounding chromatin context. To understand global trends, the insulation scores for each window position across boundaries were averaged within each boundary category and condition. Error bars were computed by taking the 2.5 th and 97.5 th percentile of the distribution of the sampling means generated via a bootstrapping procedure in which the insulation score values of boundaries in a particular class were sampled with replacement 1,000 times. A high insulation score over a bin implies that many contacts between the 200kb of chromatin directly downstream of the bin and the 200kb directly upstream of the bin pass over the bin, or equivalently, that the bin does not prevent contacts at this range from passing over the bin. Low values of insulation score correspond to well-insulated/strong boundaries. We repeated this insulation score analysis on our 10kb contact matrices, using a variety of window sizes. The results presented in Figures S6E and S6F were obtained by precisely matching the insulation score window size (200kb by 200kb) and non-overlapping sliding window genomic positions to those used in the 40kb analysis.
